In terms of COVID-19’s effect on reproductive potency, it has been established that angiotensin-converting enzyme 2 (ACE2) is a shared component of both the reproductive biological processes while serving as a binding site for COVID-19 to achieve cell entry. This evidence concerns the gene ACE2 and COVID-19.